Medicare Enrolled
Dr. Sameh Mikhail, M.D.
Hematology · Columbus, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mikhail from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mikhail?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mikhail
Dr. Sameh Mikhail is a hematology specialist in Columbus, OH, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mikhail performed 22,986 Medicare services across 1,300 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mikhail received a total of $99,562 from 85 pharmaceutical and/or device companies across 445 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mikhail is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 4% volume in OH
$99,562 industry payments
Medicare Practice Summary
Medicare Utilization ↗22,986
Medicare services
Top 4% in OH for hematology
1,300
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,210 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
10,236 | $0 | $1 |
| Anti-nausea injection (aprepitant) | 5,980 | $1 | $6 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,000 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,540 | $1 | $41 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
799 | $8 | $29 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
425 | $90 | $390 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
291 | $93 | $421 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
181 | $8 | $9 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
171 | $11 | $66 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
143 | $21 | $103 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
122 | $71 | $210 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
119 | $62 | $277 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
104 | $44 | $371 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
102 | $46 | $205 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
101 | $160 | $738 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
76 | $1 | $4 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
69 | $10 | $67 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
66 | $21 | $164 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
61 | $125 | $550 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
46 | $39 | $180 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
40 | $2 | $9 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
33 | $5 | $16 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
32 | $47 | $208 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
29 | $113 | $509 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
27 | $9 | $40 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
26 | $771 | $4,447 |
| New patient office visit, complex (60-74 min) | 26 | $161 | $673 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
25 | $61 | $214 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
24 | $98 | $406 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
23 | $29 | $269 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
20 | $68 | $334 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
19 | $26 | $121 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 18 | $81 | $1,533 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
12 | $16 | $71 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.6% high complexity
88.9% medium
8.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$99,562
Total received (2018-2024)
Avg $14,223/year across 7 years
Top 15% in OH for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
85
Companies
445
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$51,913 (52.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$39,213 (39.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,435 (8.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$18,056
2023
$5,843
2022
$30,821
2021
$15,985
2020
$5,612
2019
$14,197
2018
$9,049
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
EMD Serono, Inc.
$7,416
JAZZ PHARMACEUTICALS INC.
$3,349
BeiGene USA, Inc.
$1,625
BTG International, Inc.
$1,500
TAIHO ONCOLOGY, INC.
$1,148
Daiichi Sankyo Inc.
$948
Novartis Pharmaceuticals Corporation
$209
Eisai Inc.
$191
PFIZER INC.
$190
Merck Sharp & Dohme LLC
$168
Adaptive Biotechnologies Corporation
$149
Janssen Scientific Affairs, LLC
$131
Aveo Pharmaceuticals, Inc.
$93
AstraZeneca Pharmaceuticals LP
$65
Takeda Pharmaceuticals U.S.A., Inc.
$59
Celgene Corporation
$58
Astellas Pharma US Inc
$50
SpringWorks Therapeutics, Inc.
$48
SOBI, INC
$48
Lilly USA, LLC
$44
SERVIER PHARMACEUTICALS LLC
$43
Pharmacosmos Therapeutics Inc.
$38
Genmab U.S., Inc.
$36
Genentech USA, Inc.
$34
Kite Pharma, Inc.
$33
Karyopharm Therapeutics Inc.
$33
E.R. Squibb & Sons, L.L.C.
$31
Legend Biotech USA Inc.
$31
GlaxoSmithKline, LLC.
$27
ARRAY BIOPHARMA INC
$27
Rigel Pharmaceuticals, Inc.
$27
Gilead Sciences, Inc.
$22
Ipsen Biopharmaceuticals, Inc
$22
Regeneron Healthcare Solutions, Inc.
$21
Incyte Corporation
$21
ABBVIE INC.
$19
Stemline Therapeutics Inc.
$19
Agios Pharmaceuticals, Inc.
$18
Sumitomo Pharma America, Inc.
$17
Fennec Pharmaceuticals, Inc.
$17
ADC Therapeutics America, Inc.
$14
Blueprint Medicines Corporation
$14
Top 3 companies account for 68.6% of 2024 payments
All-time payments by company (2018-2024) ›
Ipsen Biopharmaceuticals, Inc
$35,374
EMD Serono, Inc.
$7,550
Bayer HealthCare Pharmaceuticals Inc.
$7,163
Deciphera Pharmaceuticals Inc.
$5,740
Rigel Pharmaceuticals, Inc.
$5,411
Eisai Inc.
$4,858
PFIZER INC.
$4,034
TAIHO ONCOLOGY, INC.
$3,385
JAZZ PHARMACEUTICALS INC.
$3,382
Seagen Inc.
$3,108
Daiichi Sankyo Inc.
$2,971
BeiGene USA, Inc.
$2,441
Janssen Biotech, Inc.
$1,798
Seattle Genetics, Inc.
$1,631
BTG International, Inc.
$1,500
CTI BioPharma Corp.
$1,476
Epizyme, Inc.,
$1,317
Takeda Pharmaceuticals U.S.A., Inc.
$549
EISAI INC.
$483
AstraZeneca Pharmaceuticals LP
$409
Merck Sharp & Dohme LLC
$331
Novartis Pharmaceuticals Corporation
$317
Karyopharm Therapeutics Inc.
$244
E.R. Squibb & Sons, L.L.C.
$239
Exelixis Inc.
$225
Novocure GmbH
$200
Incyte Corporation
$183
Genentech USA, Inc.
$178
Celgene Corporation
$177
ARRAY BIOPHARMA INC
$170
Adaptive Biotechnologies Corporation
$149
Sirtex Medical Inc
$142
Janssen Scientific Affairs, LLC
$131
GENZYME CORPORATION
$128
Taiho Oncology, Inc.
$118
Amgen Inc.
$112
Coherus Biosciences Inc.
$94
Aveo Pharmaceuticals, Inc.
$93
GlaxoSmithKline, LLC.
$92
Gilead Sciences, Inc.
$82
ADC Therapeutics America, Inc.
$72
AMAG Pharmaceuticals, Inc.
$69
Astellas Pharma US Inc
$67
Dendreon Pharmaceuticals LLC
$65
Blueprint Medicines Corporation
$61
Lilly USA, LLC
$59
Foundation Medicine, Inc.
$58
Mirati Therapeutics, Inc.
$56
Regeneron Healthcare Solutions, Inc.
$52
Pharmacosmos Therapeutics Inc.
$51
Kite Pharma, Inc.
$48
SpringWorks Therapeutics, Inc.
$48
SOBI, INC
$48
Acceleron Pharma, Inc.
$47
Pharmacyclics LLC, an AbbVie Company
$46
Merck Sharp & Dohme Corporation
$45
SERVIER PHARMACEUTICALS LLC
$43
Alexion Pharmaceuticals, Inc.
$41
Acrotech Biopharma LLC
$39
Pharmacyclics LLC, An AbbVie Company
$38
Stemline Therapeutics Inc.
$38
ABBVIE INC.
$37
Genmab U.S., Inc.
$36
Sumitomo Pharma America, Inc.
$31
Legend Biotech USA Inc.
$31
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
TerSera Therapeutics LLC
$28
Bayer Healthcare Pharmaceuticals Inc.
$27
Heron Therapeutics, Inc.
$25
AVEO Pharmaceuticals, Inc.
$21
AbbVie, Inc.
$21
Amneal Pharmaceuticals LLC
$18
Agios Pharmaceuticals, Inc.
$18
Fennec Pharmaceuticals, Inc.
$17
PharmaEssentia USA Corporation
$16
ImmunoGen, Inc.
$15
Secura Bio, Inc.
$15
Spectrum Pharmaceuticals Inc.
$14
TESARO, Inc.
$13
Janssen Pharmaceuticals, Inc
$13
Puma Biotechnology, Inc.
$13
Dova Pharmaceuticals
$13
Aurobindo Pharma USA, Inc.
$12
Lexicon Pharmaceuticals, Inc.
$11
Clovis Oncology, Inc.
$9
Top 3 companies account for 50.3% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AVASTIN · AYVAKIT · Abraxane · Alecensa · BAVENCIO · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABOMETYX · COSELA · CREON · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELITEK · ENHERTU · ERLEADA · EXKIVITY · Elahere · Enhertu · Epkinly · FERAHEME · FOLOTYN · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · Folotyn · GAVRETO · GAZYVA · GILOTRIF · HEMADY · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INQOVI · JAKAFI · JAYPIRCA · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MONOFERRIC · NINLARO · Nerlynx · Neulasta · Nexavar · Nubeqa · OGSIVEO · OJJAARA · ONIVYDE · ONUREG · OPDIVO · ORGOVYX · OXBRYTA · Onivyde · Orserdu · PADCEV · PEMAZYRE · PLUVICTO · PROVENGE · PYRUKYND · Padcev · Pedmark · Pomalyst · QINLOCK · REBLOZYL · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SUSTOL · Stivarga · Sustol · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TEPMETKO · TEVIMBRA · TUKYSA · Tavalisse · Tazverik · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · Venclexta · Vistogard · Vonjo · Voranigo · XALKORI · XARELTO · XGEVA · XPOVIO · Xermelo · Xofigo · Xospata · Yescarta · ZEJULA · ZEPZELCA · ZIIHERA · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (52%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
Hematologists within 10 mi
44
Per 100K population
3.3
County median income
$73,795
Nearest hospital
RIVER VISTA HEALTH AND WELLNESS LLC
3.7 mi
3.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mikhail is a mixed practice specialist, with above-average Medicare volume (top 4% in OH), with speaking/promotional industry engagement in the top 15% of OH peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mikhail experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Mikhail performed 10,236 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mikhail receive payments from pharmaceutical companies?
Yes. Dr. Mikhail received a total of $99,562 from 85 companies across 445 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mikhail's costs compare to other hematologists in Columbus?
Dr. Mikhail's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mikhail) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Columbus
Browse hematologists in Columbus ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in OH
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in OH
Which OH hematologists receive the most from drug and device companies.
By company
Ipsen Biopharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Ipsen Biopharmaceuticals, Inc.
By company
EMD Serono, Inc. Payments to Doctors
See all physicians who received payments from EMD Serono, Inc.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology